|
August 2004
return
to newsletter contents page
FDA Recommended Seizure on Illegal
Horse Drugs Carried out by U.S. Marshals Under Court Order
|
|
 |
At the request of
the Food and Drug Administration (FDA), the U.S. District Court for the
Eastern District of Kentucky issued a seizure warrant on August 11,
2004, for various illegally compounded drug products for use in horses
found at BET Pharm, LLC, Lexington, KY. The U.S. Marshals Service
executed the seizure warrant on August 12, 2004.
FDA inspections of
BET Pharm, LLC, revealed the firm is illegally manufacturing and
distributing unapproved animal drugs intended for various uses in
horses. These drug products and their components were subject to seizure
by the federal government because the drug products were not approved by
FDA as new |
|
animal drugs and
thus are adulterated under the Federal Food, Drug, and Cosmetic Act.
BET Pharm, LLC,
was previously issued a Warning Letter outlining unacceptable practices.
The Warning Letter cited violations including manufacturing drug
products from bulk drugs without approval from FDA; compounding of drug
products that are copies of approved drugs, and selling compounded drugs
in the absence of a valid relationship between a veterinarian and horse
owner. The company was given an opportunity to correct the violations,
but failed to take appropriate actions.
These violations
could pose a health risk to horses because the safety and efficacy of
these drugs are not known. The FDA advises horse owners not to purchase
or use these products. Horse owners may wish to consult their
veterinarians for advice on which products are appropriate to treat
their animals.
The FDA has
initiated this action as part of its responsibility to promote and
protect the health of animals by enforcing the animal drug, device, and
feed provisions of the Federal Food, Drug, and Cosmetic Act. FDA's
mission includes ensuring the safety or safety and effectiveness of a
broad spectrum of regulated animal products, including feed, drugs, and
veterinary devices. |
|
© 2004 American
Veterinary Distributors Association
You are
receiving this email as a benefit of your membership with AVDA. You
are not receiving this message because you are subscribed to an
electronic list. If you have any input you would like to provide
about mailings of this type, please e-mail jackie@ksgroup.org.
To unsubscribe to this newsletter, click here. |
|
Links
from this article
FDA Home Page
|